Sean M. Grimmond

305 Grattan Street
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Journal: Endocrine-related cancer

Published: April 20, 2026

Identifying High-Risk Stage I NSCLC: The Promises and Pitfalls of Tumor-Informed ctDNA.

Identifying High-Risk Stage I NSCLC: The Promises and Pitfalls of Tumor-Informed ctDNA.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 21, 2026

KRAS internal tandem duplications and alternative driver variants in BRAF Val600Glu negative hairy cell leukemia.

KRAS internal tandem duplications and alternative driver variants in BRAF Val600Glu negative hairy cell leukemia.

Journal: Leukemia & lymphoma

Published: January 13, 2026

Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

Journal: medRxiv : the preprint server for health sciences

Published: November 19, 2025

Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.

Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.

Journal: Microbiology spectrum

Published: July 23, 2025

Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma.

Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma.

Journal: Endoscopy international open

Published: May 02, 2025

Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial.

Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 20, 2025

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Journal: Genome medicine

Published: March 12, 2025

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

Journal: The New England journal of medicine

Published: February 12, 2025

Genomic mechanisms associated with resistance to PDL1-blockade in a patient with mantle cell lymphoma.

Genomic mechanisms associated with resistance to PDL1-blockade in a patient with mantle cell lymphoma.

Journal: Leukemia & lymphoma

Published: December 22, 2024

Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Journal: Nature medicine

Published: September 24, 2024

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Journal: Nature communications

Published: August 08, 2024

Showing 1-12 of 139

Last Updated: 09/26/2026